(Q43168687)

English

Combined treatment with dipeptidyl peptidase 4 (DPP4) inhibitor sitagliptin and elemental diets reduced indomethacin-induced intestinal injury in rats via the increase of mucosal glucagon-like peptide-2 concentration

scientific article published on 28 January 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Combined treatment with dipeptidyl peptidase 4 (DPP4) inhibitor sitagliptin and elemental diets reduced indomethacin-induced intestinal injury in rats via the increase of mucosal glucagon-like peptide-2 concentration (English)

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Jonathan D Kaunitz

17

object named as

Jonathan D Kaunitz

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

author name string

Kaori Fujiwara

1

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Takuya Inoue

2

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Naoki Yorifuji

3

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Munetaka Iguchi

4

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Taisuke Sakanaka

5

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Ken Narabayashi

6

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Kazuki Kakimoto

7

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Sadaharu Nouda

8

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Toshihiko Okada

9

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Kumi Ishida

10

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Yosuke Abe

11

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Daisuke Masuda

12

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Toshihisa Takeuchi

13

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Shinya Fukunishi

14

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Eiji Umegaki

15

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Yasutada Akiba

16

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Kazuhide Higuchi

18

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

publication date

28 January 2015

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

Journal of Clinical Biochemistry and Nutrition

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

56

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

2

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

155-162

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

The impact of non-steroidal anti-inflammatory drugs on the small intestinal epithelium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Nonsteroidal anti-inflammatory drug-induced visible and invisible small intestinal injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Dipeptidyl peptidase IV inhibition potentiates amino acid- and bile acid-induced bicarbonate secretion in rat duodenum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

The in vivo expression of dipeptidyl peptidases 8 and 9.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Present status and strategy of NSAIDs-induced small bowel injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Nutritional regulation of glucagon-like peptide-1 secretion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

The multiple faces of glucagon-like peptide-1--obesity, appetite, and stress: what is next? A review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

The dose of aspirin for the prevention of cardiovascular and cerebrovascular events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

Elemental diet as primary treatment of acute Crohn's disease: a controlled trial

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

25 May 2018

https://pubmed.ncbi.nlm.nih.gov/25759522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dipeptidyl peptidase IV inhibition prevents the formation and promotes the healing of indomethacin-induced intestinal ulcers in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

15 August 2018

Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

15 August 2018

Intestinal hormones and growth factors: effects on the small intestine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

15 August 2018

Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

15 August 2018

Involvement of the active metabolites in the inhibitory activity of K579 on rat plasma dipeptidyl peptidase IV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

15 August 2018

Effects of combination treatment with dipeptidyl peptidase IV inhibitor and sulfonylurea on glucose levels in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

15 August 2018

Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

15 August 2018

Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4345177

15 August 2018

Regional expression of epithelial dipeptidyl peptidase IV in the human intestines

1 reference

https://pubmed.ncbi.nlm.nih.gov/25759522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25759522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dipeptidyl peptidase expression during experimental colitis in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/25759522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/25759522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease: cytokine production and endoscopic and histological findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/25759522

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3164/JCBN.14-111

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43168687&oldid=1982790871"